Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19

Medicine and Dentistry

• Endoplasmic Reticulum Stress 100%
• COVID-19 66%
• Anti-Inflammatory Drug 66%
• Combination Therapy 50%
• Antioxidant 33%
• Virus Infection 33%
• Binding Site 33%
• Antivirus Agent 33%
• Severe Acute Respiratory Syndrome Coronavirus 2 33%
• Andrographolide 33%
• Clinical Trial 33%
• Protein 16%
• Melatonin 16%
• Host Cell 16%
• Calcium Ion 16%
• Biological Activity 16%
• Viral Protein 16%
• Respiratory Disease 16%
• Unfolded Protein Response 16%
• Chloroquine 16%
• Antiviral Activity 16%
• Drug 16%
• Chemotherapeutic Agent 16%
• Antipyretic 16%
• Hydroxychloroquine 16%
• SARS Coronavirus 16%
• Remdesivir 16%
• Andrographis paniculata 16%
• Therapeutic Procedure 16%
• Comprehension 16%
• Immunomodulation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Binding Site 33%
• Combination Therapy 33%
• Antioxidant 33%
• Virus Infection 33%
• Antivirus Agent 33%
• Andrographolide 33%
• Protein 16%
• Calcium Ion 16%
• Melatonin 16%
• Reactive Oxygen Metabolite 16%
• Antipyretic Agent 16%
• Drug 16%
• Chloroquine 16%
• Antimalarial Agent 16%
• Viral Protein 16%
• Respiratory Tract Disease 16%
• Severe Acute Respiratory Syndrome 16%
• SARS Coronavirus 16%
• Hydroxychloroquine 16%
• Remdesivir 16%
• Andrographis paniculata 16%
• Virus 16%